Lexagene Holdings Inc V.LXG

Primary Symbol: LXXGQ

Healthcare Medical Devices

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.

GREY:LXXGQ - Post by User

Lexagene Holdings Inc > Lexagene Potential Monthly Income From Test Sales

<< Previous

Bullboard Posts

Next >>

Comment by iamjunobazon May 20, 2020 11:37am

76 Views

Post# 31051549

RE:RE:RE:Lexagene Potential Monthly Income From Test Sales

The testing costs are not assumptions and pretty close to what are actual costs

The sale of units is an estimate but every sales organisation has a sales budget. The question will be what is the sales budget and what will be achieved against it

so how about you have a think on how many unfits they can sell

<< Previous

Bullboard Posts

Next >>

Invest wiser with BMO's InvestorLine Platform features